Justin Buls
Family Medicine · Kalispell, MTNPI 1467678623
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by AstraZeneca at 30.1% of the total.
Across 12 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$59
- GSK$51
- Corium, LLC$31
- AbbVie$29
- Novo Nordisk$14
- Boehringer Ingelheim$11
Across 155 payments — averaging $5344.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$632K
- Pfizer$86K
- Sanofi US Services Inc.$55K
- Cleerly, Inc.$37K
- Sanofi Pasteur Inc.$18K
What the payments were for
- Food & beverage$196100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $59 |
| GSK | 4 | $51 |
| Corium, LLC | 1 | $31 |
| AbbVie | 1 | $29 |
| Novo Nordisk | 1 | $14 |
| Boehringer Ingelheim | 1 | $11 |
How this compares
$196 in reported general payments places this provider in the 65th percentile of 426 family medicine providers in Montana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QuliptaAtogepant | 11 | $11,974 |
| Levothyroxine Sodium | 30 | $331 |
| Pantoprazole Sodium | 22 | $296 |
| Furosemide | 22 | $288 |
| Sertraline Hcl | 22 | $284 |
| Lisinopril | 23 | $282 |
| Trazodone Hcl | 22 | $266 |
| Bupropion XlBupropion Hcl | 11 | $103 |
| Losartan Potassium | 11 | $77 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieQulipta | $29 | $11,97411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 426 family medicine providers in Montana.
Other family medicine in Kalispell
- Timothy NuceKalispell$3K
- John TremperKalispell$951
- Kimberly BlakesleeMissoula$186K
- Kathleen Harder-BrouwerHamilton$28K
- Joey BanksMissoula$21K
- Julie ReilBillings$9K
- Jeanne Pereles OrtizBillings$7K
- Aubrey RemmersMissoula$5K
- Lyle OnstadGreat Falls$5K
- Carey WelshGreat Falls$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.